Navigation Links
Calcium and exercise prevents Osteoporosis

Professor Timothy Lohman and colleagues from University of Arizona has reported in the Journal Osteoporosis International// that supplementing post-menopausal women with calcium supplements and regular exercise makes their bone fit and prevents bone loss with increase in Bone Mineral Density (BMD) which highly reduces the risk of developing Osteoporosis in older women.

Osteoporosis mostly occurs in old age people and is more prominent in women than man it is caused by the weaning bone which has low levels of calcium and phosphate which is required for strong bone formation. If low levels of calcium and phosphate occur it leads to weaker bones which become more fragile and brittle which is susceptible to fractures and bone breaks.

This Bone Estrogen Strength Training (BEST) Study supplemented the study patients daily with two Citracal tablets (800 mg calcium) and regular exercise and the patients were followed up for four years and the study recruits were found to develop an increased BMD compared to recruits who did not take calcium supplements. This study has shown that regular long term supplementation of calcium and regular exercise increases the BMD which helps in maintaining the bone minerals and avoids the risk of developing osteoporosis.


'"/>




Page: 1

Related medicine news :

1. Dangers of Low Calcium Intake
2. Calcium reduces colon cancer risk
3. Calcium-blocker delays atherosclerosis than beta-blockers
4. Can Calcium Help Reduce Weight?
5. The Role Of Calcium In The Formation Of Kidney Stones
6. The Role Of Calcium In The Formation Of Kidney Stones
7. The Role Of Calcium In The Formation Of Kidney Stones
8. The Benefits Of Calcium Supplements
9. Calcium-rich Diet Good For Youngsters
10. Calcium and Vitamin D Supplements Could Be Effective In Treating Patients With Osteoporosis
11. Calcium and Vitamin D reduces risk of Premenstrual syndrome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: